KKR has acquired a majority stake in HealthCare Royalty Partners, pushing the investment firm further into the healthcare ...

KKR & Co. Inc., a leading global investment firm, today announced that it has acquired a majority ownership stake in HealthCare Royalty Partners (HCRx), a leading biopharma royalty acquisition company ...

Investment firm KKR (KKR) announced on Wednesday the acquisition of a majority stake in the biopharma royalty acquisition company, HealthCare Royalty Partners.

As part of the transaction, HCRx Chairman and CEO Clarke Futch will continue to lead the HCRx team and will maintain an ongoing substantial minority interest in HCRx.

KKR executives said strong momentum in their business gave them confidence on Thursday of beating earnings targets for 2026, ...

Investment giant KKR reported a 9% rise in adjusted net income for the second quarter on Thursday, bolstered by an increase ...

Inside KKR's bold $1 trillion playbook: data centers, Harley deals, and the biggest credit fund in its history.

Detailed price information for KKR & Company LP (KKR-N) from The Globe and Mail including charting and trades.

Ajax Health's announcement of the creation of FlowMod in collaboration with KKR (NYSE:KKR) marked a significant strategic alliance aimed at addressing heart failure. Despite such forward-looking ...

KKR will pay 49p per share, a premium of 31.9% on the 37.4p per Assura share on 14 February 2025 when the bidding started. It values Assura at approximately £1,608 million.

KKR & Co., the buyout firm that’s been scouting for takeover targets amid the recent market volatility, is considering a potential acquisition of Italian health-care technology firm GPI SpA ...